Family Medicine · Lamar, SC
NPI
1588637771
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
301 W Main St
Lamar, SC, 29069
Phone (843) 395-8400
Groups this clinician bills Medicare through
Medicare paid, 2024
$63K
7,240 services
Medicare patients, 2024
191
Average age 75
Drug cost, 2024
$2.0M
7,728 prescriptions
Company payments, 2025
$849
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael Barrett was code 85025 (blood count), 572 times for 189 patients. In total Michael Barrett billed 7,240 services in 71 codes, and Medicare paid $63K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 85025 Blood Count | Office | 572 | 189 | $7.56 | $4,323 |
| 80048 Clinical Chemistry | Office | 566 | 188 | $8.28 | $4,684 |
| 80076 Clinical Chemistry | Office | 559 | 188 | $7.97 | $4,454 |
| 84550 Clinical Chemistry | Office | 556 | 188 | $4.41 | $2,454 |
| 83735 Clinical Chemistry | Office | 555 | 188 | $6.53 | $3,624 |
| 81003 Clinical Chemistry | Office | 476 | 175 | $2.20 | $1,047 |
| 82043 Clinical Chemistry | Office | 472 | 161 | $5.65 | $2,666 |
| 82570 Clinical Chemistry | Office | 431 | 148 | $5.06 | $2,179 |
| 84156 Clinical Chemistry | Office | 419 | 141 | $3.59 | $1,505 |
| 83721 Clinical Chemistry | Office | 371 | 170 | $10.21 | $3,787 |
| 84478 Clinical Chemistry | Office | 364 | 168 | $5.62 | $2,045 |
| 83036 Blood Count | Office | 323 | 111 | $9.48 | $3,061 |
| 82985 Clinical Chemistry | Office | 305 | 101 | $16.42 | $5,008 |
| 84443 Clinical Chemistry | Office | 236 | 162 | $16.43 | $3,876 |
| 84439 Clinical Chemistry | Office | 236 | 162 | $8.82 | $2,080 |
By year: 2022 $59K for 7,109 services; 2023 $66K for 8,053 services; 2024 $63K for 7,240 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 572 | 189 | $7.56 | $4,323 |
| 80048 Clinical Chemistry | 566 | 188 | $8.28 | $4,684 |
| 80076 Clinical Chemistry | 559 | 188 | $7.97 | $4,454 |
| 84550 Clinical Chemistry | 556 | 188 | $4.41 | $2,454 |
| 83735 Clinical Chemistry | 555 | 188 | $6.53 | $3,624 |
| 81003 Clinical Chemistry | 476 | 175 | $2.20 | $1,047 |
| 82043 Clinical Chemistry | 472 | 161 | $5.65 | $2,666 |
| 82570 Clinical Chemistry | 431 | 148 | $5.06 | $2,179 |
| 84156 Clinical Chemistry | 419 | 141 | $3.59 | $1,505 |
| 83721 Clinical Chemistry | 371 | 170 | $10.21 | $3,787 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael Barrett prescribed most often to Medicare patients was Atorvastatin Calcium, with 286 prescriptions and refills. In total Michael Barrett wrote 7,728 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 286 | 693 | 100 | $3,282 |
| Eliquis Apixaban | 191 | 216 | 20 | $86K |
| Pravastatin Sodium Generic | 166 | 430 | 47 | $2,907 |
| Januvia Sitagliptin Phosphate | 156 | 405 | 43 | $217K |
| Levothyroxine Sodium Generic | 155 | 320 | 29 | $2,812 |
| Amlodipine Besylate Generic | 142 | 326 | 49 | $1,048 |
| Omeprazole Generic | 129 | 336 | 40 | $2,016 |
| Fluticasone Propionate Generic | 125 | 210 | 50 | $1,714 |
| Tramadol Hcl Generic | 120 | 120 | 29 | $1,488 |
| Gabapentin Generic | 119 | 213 | 40 | $1,596 |
| Metformin Hcl Er Metformin Hcl | 114 | 340 | 33 | $1,182 |
| Metformin Hcl Generic | 112 | 326 | 34 | $1,080 |
| Spironolactone Generic | 110 | 207 | 34 | $1,086 |
| Ibuprofen Generic | 109 | 134 | 31 | $1,114 |
| Potassium Chloride Generic | 109 | 303 | 40 | $1,920 |
Brand drugs: 2,416 claims; generic drugs: 5,267 claims; opioid claims: 213.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael Barrett $849 ($849 in general payments such as food, travel and fees) from 14 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $182.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 9 | $182 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $114 |
| Esperion Therapeutics, Inc. ESPR | 6 | $101 |
| Abbott Laboratories ABT | 5 | $97.53 |
| Amgen Inc. AMGN | 4 | $78.91 |
| Corcept Therapeutics CORT | 3 | $74.31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $63.63 |
| Lilly USA, LLC LLY | 3 | $43.54 |
| Novo Nordisk Inc NVO | 1 | $18.44 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $17.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.